Disease‐related thrombocytopenia in myelofibrosis is defined by distinct genetic etiologies and is associated with unique prognostic correlates-Reference-Cited by-同舟云学术

Disease‐related thrombocytopenia in myelofibrosis is defined by distinct genetic etiologies and is associated with unique prognostic correlates

Published:2022-08-09 Issue:19 Volume:128 Page:3495-3501
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Kuykendall Andrew T.¹^ORCID,Mo Qianxing¹,Sallman David A.¹,Ali Najla Al¹,Chan Onyee¹,Yun Seongseok¹,Sweet Kendra L.¹,Padron Eric¹,Lancet Jeffrey E.¹,Komrokji Rami S.¹

Affiliation:

1. Moffitt Cancer Center, Tampa Florida USA

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.34414

Reference48 articles.

1. MIPSS70+ Version 2.0: Mutation and Karyotype-Enhanced International Prognostic Scoring System for Primary Myelofibrosis

2. MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis

3. DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status

4. A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis

5. JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cross-Study Comparisons of JAK2 Inhibitors in Myelofibrosis: Risks and Recommendations;Clinical Lymphoma Myeloma and Leukemia;2023-10

2. Association of Myelofibrosis Phenotypes with Clinical Manifestations, Molecular Profiles, and Treatments;Cancers;2023-06-24